Susquehanna International Group
AXDX

Susquehanna International Group’s Accelerate Diagnostics AXDX Stock Holding History

Susquehanna International Group’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-55,268
Closed -$38.7K – 12631
2025
Q1 		$38.7K Buy
55,268
+25,616
+86% +$29.2K ﹤0.01% 11937
2024
Q4 		$35.6K Buy
+29,652
New +$49.2K ﹤0.01% 11799
2023
Q1 		– Sell
-10,212
Closed -$72.1K – 12543
2022
Q4 		$72.1K Sell
10,212
-40,821
-80% -$446K ﹤0.01% 11202
2022
Q3 		$776K Buy
51,033
+31,755
+165% +$526K ﹤0.01% 7312
2022
Q2 		$191K Buy
19,278
+8,495
+79% +$75.1K ﹤0.01% 10704
2022
Q1 		$155K Sell
10,783
-7,366
-41% -$210K ﹤0.01% 11528
2021
Q4 		$947K Buy
18,149
+2,470
+16% +$138K ﹤0.01% 7444
2021
Q3 		$914K Sell
15,679
-2,289
-13% -$149K ﹤0.01% 7807
2021
Q2 		$1.45M Buy
17,968
+5,180
+41% +$412K ﹤0.01% 6742
2021
Q1 		$1.06M Buy
12,788
+1,235
+11% +$125K ﹤0.01% 7575
2020
Q4 		$876K Buy
11,553
+3,210
+38% +$287K ﹤0.01% 7027
2020
Q3 		$889K Sell
8,343
-18,716
-69% -$2.6M ﹤0.01% 6401
2020
Q2 		$4.1M Buy
27,059
+14,822
+121% +$1.46M ﹤0.01% 3289
2020
Q1 		$1.02M Sell
12,237
-19,934
-62% -$2.8M ﹤0.01% 5356
2019
Q4 		$5.44M Buy
32,171
+5,601
+21% +$924K ﹤0.01% 2868
2019
Q3 		$4.93M Buy
26,570
+2,682
+11% +$518K ﹤0.01% 2746
2019
Q2 		$5.47M Buy
23,888
+21,701
+992% +$4.24M ﹤0.01% 2593
2019
Q1 		$460K Sell
2,187
-14,958
-87% -$2.8M ﹤0.01% 6434
2018
Q4 		$1.97M Sell
17,145
-29,914
-64% -$4.43M ﹤0.01% 3539
2018
Q3 		$10.8M Buy
47,059
+32,041
+213% +$7.08M ﹤0.01% 1849
2018
Q2 		$3.35M Sell
15,018
-2,701
-15% -$604K ﹤0.01% 3244
2018
Q1 		$4.05M Buy
+17,719
New +$4.65M ﹤0.01% 2805
2017
Q4 		– Sell
-14,983
Closed -$3.51M – 9217
2017
Q3 		$3.36M Sell
14,983
-9,441
-39% -$2.32M ﹤0.01% 3059
2017
Q2 		$6.68M Buy
24,424
+16,258
+199% +$4.41M ﹤0.01% 2070
2017
Q1 		$1.98M Sell
8,166
-8,111
-50% -$1.85M ﹤0.01% 3745
2016
Q4 		$3.38M Buy
16,277
+4,312
+36% +$1.02M ﹤0.01% 3031
2016
Q3 		$3.26M Buy
11,965
+8,668
+263% +$1.92M ﹤0.01% 2779
2016
Q2 		$474K Sell
3,297
-2,070
-39% -$278K ﹤0.01% 6211
2016
Q1 		$771K Buy
5,367
+3,167
+144% +$447K ﹤0.01% 5600
2015
Q4 		$473K Sell
2,200
-803
-27% -$147K ﹤0.01% 6877
2015
Q3 		$486K Buy
3,003
+1,294
+76% +$280K ﹤0.01% 7178
2015
Q2 		$441K Sell
1,709
-1,859
-52% -$444K ﹤0.01% 7864
2015
Q1 		$803K Buy
3,568
+1,607
+82% +$336K ﹤0.01% 6192
2014
Q4 		$376K Buy
1,961
+601
+44% +$129K ﹤0.01% 7760
2014
Q3 		$292K Buy
1,360
+116
+9% +$22.6K ﹤0.01% 8069
2014
Q2 		$324K Buy
+1,244
New +$272K ﹤0.01% 8249
2014
Q1 		– Sell
-4,264
Closed -$632K – 8866
2013
Q4 		$520K Buy
+4,264
New +$570K ﹤0.01% 6626

Other funds holding AXDX

BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.82B AUM 15.4% 1-Year Est. Return

Susquehanna International Group's AXDX Position: Q2 2025 in Review

Susquehanna International Group sold out of Accelerate Diagnostics (AXDX) in Q2 2025, closing a stake of 55,268 shares — an estimated $38.7K sold.

Susquehanna International Group first reported a position in AXDX in Q4 2013 and held it in 37 quarters. The position peaked at $10.8M in Q3 2018. 3 funds tracked by Wall St. Rank hold AXDX as of Q2 2025.

  • Susquehanna International Group reported no remaining Accelerate Diagnostics position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 55,268 Accelerate Diagnostics shares in Q2 2025, an estimated $38.7K.
  • Susquehanna International Group first reported a position in Accelerate Diagnostics in Q4 2013 and held it in 37 quarters.
  • Susquehanna International Group's Accelerate Diagnostics position peaked at $10.8M in Q3 2018.
  • 3 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.